Research summary ·
Effect of testosterone replacement therapy on fracture risk in hypogonadal men: A systematic review and meta-analysis of randomized controlled trials.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This review pooled results from earlier trials. It looked at men with hypogonadism who got testosterone treatment. The question was whether this treatment changes the risk of broken bones. Only trials where men were put into groups by chance were used. The team searched research databases up to 30 September 2025. In the end, the review held data on 2711 men.
What they found
The search first turned up 1145 papers. Men on testosterone had more broken bones than men on a dummy drug. Most of these breaks were not of the major types. Major types here meant the hip, spine, wrist and arm. For these major breaks, the groups did not clearly differ. Hip breaks and spine breaks, looked at alone, also showed no clear gap.
What it means for patients
The authors say testosterone treatment was linked to more fractures. These were mostly fractures outside the major types. The risk of major fractures, such as hip or spine, did not rise. The abstract notes the treatment is known to help bone density.
Why it is not certain yet
Only a few trials met the rules for this review. The results for major fractures differed a lot between trials. For hip and spine breaks, the range of likely results was wide. So these results are not firm. A review can only be as good as the studies in it.
Source
Effect of testosterone replacement therapy on fracture risk in hypogonadal men: A systematic review and meta-analysis of randomized controlled trials.
PubMed · PMID 42066666We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Male hypogonadism publications